Research Papers:

MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma

Zhi-Qiang Ning, Hai-lin Lu, Chao Chen, Lin Wang, Wei Cai, Yan Li, Ting-hua Cao, Jing Zhu, Yong-Qian Shu and Hua Shen _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:4572-4581. https://doi.org/10.18632/oncotarget.13944

Metrics: PDF 1820 views  |   HTML 2104 views  |   ?  


Zhi-Qiang Ning1,*, Hai-lin Lu1,*, Chao Chen1,*, Lin Wang2,*, Wei Cai1, Yan Li1, Ting-hua Cao1, Jing Zhu1, Yong-Qian Shu3,4, Hua Shen3,4

1Department of Oncology, The First People's Hospital of Wujiang District, Suzhou, 215200, China

2Institute of Medcine, University of Zhengzhou, Henan Province, 450000, China

3Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China

4Collaborative Innovation Center for Cancer Medicine, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China

*These authors contributed equally to this work

Correspondence to:

Hua Shen, email: [email protected]

Yong-Qian Shu, email: [email protected]

Keywords: miRNA-30e, chemosensitivity, gefitinib, HOXA1, lung cancer

Received: May 28, 2016     Accepted: December 06, 2016     Published: December 15, 2016


MicroRNAs (miRNAs) play critical roles in variousbiological processes,including malignancy. Here, we demonstrated that miR-30e levels were markedly reduced in human lung carcinoma specimens in comparisonwith adjacent normal tissues.In addition, miR-30eamounts were starkly lower in the resistant PC9/gefitinib (PC9G) cancer cells compared with PC9 cells. Meanwhile, miR-30eoverexpression inPC9G cells resulted in reduced cell proliferation and migration,reversing drug resistance to gefitinib.Conversely,miR-30e silencing in PC9 cells increased proliferation as well as migration, and conferred resistance to gefitinib.Moreover, HOXA1, which was identified asa new miR-30etarget, plays important roles in regulating cell fate, early developmental patterns and organogenesis.Importantly, miR-30ealso inhibited PC9G growth in vivo. Taken together, these findings demonstrated that miR-30eshould be considered a tumor suppressor miRNA, which could be used in treatinghuman lung cancer.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13944